<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kemsu</journal-id><journal-title-group><journal-title xml:lang="ru">СибСкрипт</journal-title><trans-title-group xml:lang="en"><trans-title>SibScript</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2949-2122</issn><issn pub-type="epub">2949-2092</issn><publisher><publisher-name>Kemerovo State University</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">kemsu-2792</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>ПОЛИМОРФИЗМ ГЕНА VKORC1 (C1173T), ОПРЕДЕЛЯЮЩЕГО ЧУВСТВИТЕЛЬНОСТЬ ИНДИВИДОВ К ВАРФАРИНУ, В ПОПУЛЯЦИЯХ КОРЕННЫХ ЭТНОСОВ СЕЛЬКУПОВ И ТУНДРОВЫХ НЕНЦЕВ, А ТАКЖЕ У РУССКИХ СЕВЕРНОЙ СИБИРИ</article-title><trans-title-group xml:lang="en"><trans-title>THE POLYMORPHISM OF THE VKORC1 (C1173T) GENE, DETERMINING INDIVIDUAL SUSCEPTIBILITY TO WARFARIN, IN POPULATIONS OF INDIGENOUS PEOPLES OF SELKUPS AND TUNDRA NENETS AND IN THE RUSSIANS OF NORTHERN SIBERIA</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Корчагина</surname><given-names>Роза Павловна</given-names></name><name name-style="western" xml:lang="en"><surname>Korchagina</surname><given-names>Roza Pavlovna</given-names></name></name-alternatives><email xlink:type="simple">kruosana@mail.ru &lt;mailto:Kruosana@mail.ru&gt;</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипова</surname><given-names>Людмила Павловна</given-names></name><name name-style="western" xml:lang="en"><surname>Osipova</surname><given-names>Ludmila Pavlovna</given-names></name></name-alternatives><email xlink:type="simple">ludos84@mail.ru &lt;mailto:ludos84@mail.ru&gt;</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вавилова</surname><given-names>Наталья Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Vavilova</surname><given-names>Natalya Alexandrovna</given-names></name></name-alternatives><email xlink:type="simple">senk_off@mail.ru &lt;mailto:senk_off@mail.ru&gt;</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронина</surname><given-names>Елена Николаевна</given-names></name><name name-style="western" xml:lang="en"><surname>Voronina</surname><given-names>Elena Nikolaevna</given-names></name></name-alternatives><email xlink:type="simple">voronina_l@mail.ru &lt;mailto:voronina_l@mail.ru&gt;</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филипенко</surname><given-names>Максим Леонидович</given-names></name><name name-style="western" xml:lang="en"><surname>Filipenko</surname><given-names>Maxim Leonidovich</given-names></name></name-alternatives><email xlink:type="simple">max@niboch.nsc.ru &lt;mailto:ma@.niboch.nsc.ru&gt;</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Институт цитологии и генетики СО РАН, Новосибирск<country>Россия</country></aff><aff xml:lang="en">Institute of Citology and Genetics of the Siberian Division of the RAS Novosibirsk<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Институт химической биологии и фундаментальной медицины СО РАН, Новосибирск<country>Россия</country></aff><aff xml:lang="en">Institute of Chemo biology and fundamental Medicine of the Siberian Division of the RAS, Novosibirsk<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">Институт химической биологии и фундаментальной медицины СО РАН, Новосибирск<country>Россия</country></aff><aff xml:lang="en">Institute of Chemo biology and fundamental Medicine of the Siberian Division of the RAS Novosibirsk<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2012</year></pub-date><pub-date pub-type="epub"><day>17</day><month>10</month><year>2012</year></pub-date><volume>0</volume><issue>1</issue><fpage>19</fpage><lpage>23</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Корчагина Р.П., Осипова Л.П., Вавилова Н.А., Воронина Е.Н., Филипенко М.Л., 2012</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="ru">Корчагина Р.П., Осипова Л.П., Вавилова Н.А., Воронина Е.Н., Филипенко М.Л.</copyright-holder><copyright-holder xml:lang="en">Korchagina R.P., Osipova L.P., Vavilova N.A., Voronina E.N., Filipenko M.L.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sibscript.ru/jour/article/view/2792">https://www.sibscript.ru/jour/article/view/2792</self-uri><abstract><p>Проведено исследование полиморфизма VKORC1 C1173T в популяциях коренных самодийских этносов, селькупов и тундровых ненцев, а также у русских Северной Сибири в связи с определением популяционной чувствительности к антикоагулянту варфарину. Показано, что в изученных самодийских популяциях, по сравнению с русскими Северной Сибири, существенно преобладает мутантный гомозиготный генотип VKORC1 1173TT, частота которого составляет 57,1 % у тундровых ненцев, 71,8 % у селькупов и 13,6 % у русских. Частоты аллеля VKORC1 1173Т у самодийцев (74,7 % у тундровых ненцев; 84,6 % у селькупов) значительно и достоверно превышают таковые для русских Северной Сибири (36,9 %). Результаты проведенного исследования могут быть использованы в протоколах дозирования варфарина в целях достижения максимально безопасной и эффективной терапии.</p></abstract><trans-abstract xml:lang="en"><p>In relation with determining population sensitivity to warfarin the study of the VKORC1 C1173T polymorphism in Northern Siberia populations of indigenous Samoedic peoples (Selkups and Tundra Nenets) and also in Russians has been conducted. It was revealed, the mutational genotype VKORC1 1173TT considerably dominations in studied Samoedic populations as compared with Russians. The frequencies of genotype VKORC1 1173TT were 57,1 % in Tundra Nenets, 71,8 % in Selkups and in 13,6 % Russians. The frequencies of VKORC1 C1173T allele in Tundra Nenets (74,7 %) and Selkups (84,6 %) essentially and reliably are above ones in Russians of Northern Siberia (36,9 %). Our data can be used in the protocols of recommendations for dosing warfarin with a view to reaching at most safe and efficient therapy in populations of native residents of Northern Siberia.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>VKORC1 C1173T</kwd><kwd>антикоагулянт варфарин</kwd><kwd>коренные этносы Северной Сибири</kwd><kwd>real-time PCR</kwd></kwd-group><kwd-group xml:lang="en"><kwd>VKORC1 C1173T</kwd><kwd>anticoagulant warfarin</kwd><kwd>indigenous peoples of Northern Siberia</kwd><kwd>real-time PCR</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Дебец, Г. Ф. Селькупы (антропологический очерк) [Текст] / Г. Ф. Дебец // Труды института этнографии. - М.; Л.: Изд-во АН СССР, 1947.</mixed-citation><mixed-citation xml:lang="en">Дебец, Г. Ф. Селькупы (антропологический очерк) [Текст] / Г. Ф. Дебец // Труды института этнографии. - М.; Л.: Изд-во АН СССР, 1947.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Осипова, Л. П. Генетические маркеры иммуноглобулинов (система Gm) для оценки процессов миграции и метисации в популяциях человека в Северной Сибири [Текст] / Л. П. Осипова // Сибирский экологический журнал. - 1994. - Т. 1. - № 2.</mixed-citation><mixed-citation xml:lang="en">Осипова, Л. П. Генетические маркеры иммуноглобулинов (система Gm) для оценки процессов миграции и метисации в популяциях человека в Северной Сибири [Текст] / Л. П. Осипова // Сибирский экологический журнал. - 1994. - Т. 1. - № 2.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Панченко, Е. П. Венозные тромбозы в терапевтической клинике. Факторы риска и возможности профилактики [Текст] / Е. П. Панченко // Сердце. - 2002. - Т. 1. - № 4. - Вып. 4.</mixed-citation><mixed-citation xml:lang="en">Панченко, Е. П. Венозные тромбозы в терапевтической клинике. Факторы риска и возможности профилактики [Текст] / Е. П. Панченко // Сердце. - 2002. - Т. 1. - № 4. - Вып. 4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Сироткина, О. В. Аллельные варианты CYP2C9*2 и CYP2C9*3 гена цитохрома CYP2C9 в популяции Санкт-Петербурга и их клиническое значение при антикоагулянтной терапии варфарином [Текст] / О. В. Сироткина, А. С. Улитина, А. Е. Тараскина и др. // Российский кардиологический журнал. - 2004. - № 6.</mixed-citation><mixed-citation xml:lang="en">Сироткина, О. В. Аллельные варианты CYP2C9*2 и CYP2C9*3 гена цитохрома CYP2C9 в популяции Санкт-Петербурга и их клиническое значение при антикоагулянтной терапии варфарином [Текст] / О. В. Сироткина, А. С. Улитина, А. Е. Тараскина и др. // Российский кардиологический журнал. - 2004. - № 6.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Сычев, Д. А. Генетическая основа чувствительности к непрямым антикоагулянтам: фокус на полиморфизм генов VKORC1 и APOE [Текст] / Д. А Сычев, И. В. Игнатьев, В. Г. Кукес // Российский кардиологический журнал. - 2005. - Т. 55.</mixed-citation><mixed-citation xml:lang="en">Сычев, Д. А. Генетическая основа чувствительности к непрямым антикоагулянтам: фокус на полиморфизм генов VKORC1 и APOE [Текст] / Д. А Сычев, И. В. Игнатьев, В. Г. Кукес // Российский кардиологический журнал. - 2005. - Т. 55.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Сычев, Д. А. Фармакогенетика непрямых антикоагулянтов: значение генотипа в повышении эффективности и безопасности терапии [Текст] / Д. А. Сычев, Е. С. Кропачева, И. В. Игнатьев и др. // Кардиология. - 2006. - № 7.</mixed-citation><mixed-citation xml:lang="en">Сычев, Д. А. Фармакогенетика непрямых антикоагулянтов: значение генотипа в повышении эффективности и безопасности терапии [Текст] / Д. А. Сычев, Е. С. Кропачева, И. В. Игнатьев и др. // Кардиология. - 2006. - № 7.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Caldwell, M. D. CYP4F2 genetic variant alters required warfarin dose [Text] / M. D. Caldwell, T. Awad, J. A. Johnson // Blood. - 2008. - Vol. 111. - No. 8.</mixed-citation><mixed-citation xml:lang="en">Caldwell, M. D. CYP4F2 genetic variant alters required warfarin dose [Text] / M. D. Caldwell, T. Awad, J. A. Johnson // Blood. - 2008. - Vol. 111. - No. 8.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Crawford, D. VKORC1 common variation and bone mineral density in the third national health and nutrition examination survey [Text] / D. Crawford, K. Brown-Gentry, M. Rieder // PLoS ONE. - 2010. - Vol. 5. - No. 12.</mixed-citation><mixed-citation xml:lang="en">Crawford, D. VKORC1 common variation and bone mineral density in the third national health and nutrition examination survey [Text] / D. Crawford, K. Brown-Gentry, M. Rieder // PLoS ONE. - 2010. - Vol. 5. - No. 12.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">D`Andrea, G. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin [Text] / G. D`Andrea, R. L. D`Ambrosio, P. D. Perna et al. // Blood. - 2005. - Vol. 105. - No. 2.</mixed-citation><mixed-citation xml:lang="en">D`Andrea, G. A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin [Text] / G. D`Andrea, R. L. D`Ambrosio, P. D. Perna et al. // Blood. - 2005. - Vol. 105. - No. 2.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">D`Andrea, G. Oral anticoagulations: Pharma-cogenetics Relationship between genetic and non-genetic factors [Text] / G. D`Andrea, R. L. D`Ambro-sio, M. Margaglione // Blood Reviews. - 2008. - Vol. 22.</mixed-citation><mixed-citation xml:lang="en">D`Andrea, G. Oral anticoagulations: Pharma-cogenetics Relationship between genetic and non-genetic factors [Text] / G. D`Andrea, R. L. D`Ambro-sio, M. Margaglione // Blood Reviews. - 2008. - Vol. 22.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lacut, K. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboem-bolism: results from the EDITH study [Text] / K. Lacut, C. Larramendy-Gozalo, G. Le Gal et al. // Journal of Thrombosis and Haemostasis. - 2007. - Vol. 5.</mixed-citation><mixed-citation xml:lang="en">Lacut, K. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboem-bolism: results from the EDITH study [Text] / K. Lacut, C. Larramendy-Gozalo, G. Le Gal et al. // Journal of Thrombosis and Haemostasis. - 2007. - Vol. 5.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Larramendy-Gozalo, C. Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C&gt;T in a Chinese and a Caucasian population [Text] / C. Larramendy-Gozalo, J. Q. Yang, C. L. Verstuyft et al. // Pharmacology and Toxicology. - 2006. - Vol. 98.</mixed-citation><mixed-citation xml:lang="en">Larramendy-Gozalo, C. Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C&gt;T in a Chinese and a Caucasian population [Text] / C. Larramendy-Gozalo, J. Q. Yang, C. L. Verstuyft et al. // Pharmacology and Toxicology. - 2006. - Vol. 98.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lee, M. VKORC1 haplotypes in five East-Asian populations and Indians [Text] / M. Lee, C. Chen, H. Chuang // Pharmacogenomics. - 2009. - Vol. 10. - No. 10.</mixed-citation><mixed-citation xml:lang="en">Lee, M. VKORC1 haplotypes in five East-Asian populations and Indians [Text] / M. Lee, C. Chen, H. Chuang // Pharmacogenomics. - 2009. - Vol. 10. - No. 10.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Limdi, N. A. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups [Text] / N. A. Limdi, M. Wadelius, Cavallari L. et al. // Blood. - 2010. - Vol. 115. - No. 18.</mixed-citation><mixed-citation xml:lang="en">Limdi, N. A. Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups [Text] / N. A. Limdi, M. Wadelius, Cavallari L. et al. // Blood. - 2010. - Vol. 115. - No. 18.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Oldenburg, J. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle [Text] / J. Oldenburg, C. G. Bevans, C. R. Muller, M. Watzka // Antioxid Redox Signal. - 2006. - Vol. 8. - No. 3 - 4.</mixed-citation><mixed-citation xml:lang="en">Oldenburg, J. Vitamin K epoxide reductase complex subunit 1 (VKORC1): the key protein of the vitamin K cycle [Text] / J. Oldenburg, C. G. Bevans, C. R. Muller, M. Watzka // Antioxid Redox Signal. - 2006. - Vol. 8. - No. 3 - 4.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Oldenburg, J. VKORC1: molecular target of coumarins [Text] / J. Oldenburg, M. Watzka, S. Rost, C. R. Muller // Journal of Thrombosis and Haemostasis. - 2007. - Vol. 5. - No. 1.</mixed-citation><mixed-citation xml:lang="en">Oldenburg, J. VKORC1: molecular target of coumarins [Text] / J. Oldenburg, M. Watzka, S. Rost, C. R. Muller // Journal of Thrombosis and Haemostasis. - 2007. - Vol. 5. - No. 1.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Osman, A. Main gaplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records [Text] / A. Osman, C. Enstrom, K. Arbring, P. Soderkvist, L. Lindahl // Journal of Thrombosis and Haemostasis. - 2006. - Vol. 4.</mixed-citation><mixed-citation xml:lang="en">Osman, A. Main gaplotypes and mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a retrospective analysis of case records [Text] / A. Osman, C. Enstrom, K. Arbring, P. Soderkvist, L. Lindahl // Journal of Thrombosis and Haemostasis. - 2006. - Vol. 4.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Reitsma, P. H. C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk [Text] / P. H. Reitsma, J. F. van der Heijden, A. P. Groot, F. R. Rosendaal, H. R. Buller // PLOS Medicine. - 2005. - Vol. 2. - No. 10.</mixed-citation><mixed-citation xml:lang="en">Reitsma, P. H. C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk [Text] / P. H. Reitsma, J. F. van der Heijden, A. P. Groot, F. R. Rosendaal, H. R. Buller // PLOS Medicine. - 2005. - Vol. 2. - No. 10.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Sirotkina, O. The vitamin K epoxide reductase gene polymorphisms and pharmacogenetics of warfarin [Text] / O. Sirotkina, A. Ulitina, A. Markov, T. Vavilova // Journal of Thrombosis and Haemostasis. - 2007. - Vol. 5. - No. 2.</mixed-citation><mixed-citation xml:lang="en">Sirotkina, O. The vitamin K epoxide reductase gene polymorphisms and pharmacogenetics of warfarin [Text] / O. Sirotkina, A. Ulitina, A. Markov, T. Vavilova // Journal of Thrombosis and Haemostasis. - 2007. - Vol. 5. - No. 2.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Suh, J. W. Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2 - Center prostective cohort study [Text] / J. W. Suh, S. H. Baek, J. S. Park et al. // Am. Heart. J. - 2009. - Vol. 157. - No. 5.</mixed-citation><mixed-citation xml:lang="en">Suh, J. W. Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2 - Center prostective cohort study [Text] / J. W. Suh, S. H. Baek, J. S. Park et al. // Am. Heart. J. - 2009. - Vol. 157. - No. 5.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Wadelius, M. Common VKORC1 and GGCX polymorphisms associated with warfarin dose [Text] / M. Wadelius, L. Y. Chen, K. Downes et al. // Pharmacogenomics Journal. - 2005. - Vol. 5.</mixed-citation><mixed-citation xml:lang="en">Wadelius, M. Common VKORC1 and GGCX polymorphisms associated with warfarin dose [Text] / M. Wadelius, L. Y. Chen, K. Downes et al. // Pharmacogenomics Journal. - 2005. - Vol. 5.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Wang, Y. Regulatory polymorphism in Vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement / Y. Wang, H. Chen, K. M. Moramy // Blood. - 2008. - Vol. 112. - No. 4.</mixed-citation><mixed-citation xml:lang="en">Wang, Y. Regulatory polymorphism in Vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement / Y. Wang, H. Chen, K. M. Moramy // Blood. - 2008. - Vol. 112. - No. 4.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
